The following businesses have submitted successful applications for early qualification as Qualified Businesses under the 2023 Angel Investor Tax Credit Program.

This certification solely means that the Massachusetts Life Sciences Center (MLSC) has found that each business listed below meets the qualifications specified in the regulations for the 830 CMR 62.6.5: Angel Investor Tax Credit and that each business is therefore eligible to participate in MLSC’s Angel Investor Tax Credit 2023 Program.

Company NameCityBusiness ActivityContact NameContact EmailWebsite
AcousticaBio, Inc.CambridgeDrug DeliveryLawrence M. Pensacklarry.pensack@acoustica.bio
AiM Medical Robotics, Inc.Worcester*Medical DeviceGregory S. Fischergfischer@aimmedrobotics.com
Angiowave Imaging Inc.ConcordMedical DeviceAram Salzmanasalzman@angiowaveimaging.comNone
AOA Dx Inc.CambridgeDiagnosticsOriana Papin Zoghbioriana.papin@aoadx.com
Biometry, Inc.Lowell*DiagnosticsBryan Nolanbryan@mybiometry.com
Cellens, Inc.CambridgeDiagnosticsPhuong (Jean) Phamjean.pham@cellensinc.com
Droplet Biosciences, Inc.CambridgeDiagnosticsJason Pulsiferjpulsifer@dropletbiosci.com
Hilltop BioSciences, Inc.MansfieldRegenerative MedicineAmanda Drobnisamanda@hilltopbio.com
Navigation Sciences, Inc.BrooklineMedical DeviceAlan Lucasalan.lucas@navigationsci.com
NED Medical, Inc.NorwellMedical DeviceRichard D. Yazbeckryazbeck@nedmedical.com
Pykus Therapeutics, Inc.CambridgeMedical DeviceJames Anthony Stefatertony@pykustherapeutics.com
Regenerative Bioelectronics, Inc.Worcester*Medical DeviceDavid N. Constantinedavid.constantine@rbimedical.com
* Companies located in a Gateway City are eligible for an increased credit of 30% of the qualifying investment.

The above data has been updated for company applications received through 10/25/2023.

No Investment Advice
The content is for informational purposes only, and such information and/or other material related to the Angel Investor Tax Credit program should not be construed as legal, tax, investment, financial or other advice.  Nothing contained in our site constitutes a solicitation, recommendation, endorsement or offer to buy or sell any securities or other financial instruments in any jurisdiction.